Goodwin has advised Trill Impact on the financing aspects of its partnership with TT medic GmbH, a MedTech development and manufacturing partner for high-quality polymer components operating in Austria, Switzerland and Germany.
Headquartered in Klosterneuburg/Austria, TT medic operates in precision medical injection molding, specializing as a contract development and manufacturing organization in clean room processing of high-quality polymer components. The company caters to several indications, including minimally invasive surgery, wound care, surgical sealants, drug delivery and ophthalmology, contributing to patient safety and improved medical outcomes across critical therapeutic areas.
Trill Impact is a pioneering Impact House with around EUR 1.2 billion in assets under management across its investment strategies, Impact Private Equity, Impact Ventures and Microfinance, with a team of around 55 experienced professionals based in the Nordics, Germany, Luxembourg and USA. Trill Impact aims to become a force for positive change through impact private investments, delivering Real Returns and Lasting Impact for the benefit of investors, businesses and society at large - encouraging others to follow.
The Goodwin team was led by partner Winfried M. Carli and included associate Daniel Wagner and transaction lawyer Rina Omura (all Finance/Private Equity, Munich) as well as partner Oded Schein and associate Philipp Lauer (both tax, Munich).
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.